In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Trump's pick for HHS Secretary faces questions from the left and right over his health stances. But will that stop his ...
One is “spread pricing,” when a PBM charges its health plan clients ... (If Trump promising to eliminate the middlemen sounds familiar, it’s because he said the same thing about PBMs in ...
"You got to figure out how to work with him, right?" PBM reform is top of mind for drugmakers. They argue that the middlemen overcharge insurance plans for which they negotiate medication rebates ...
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...